In this portion of the Pharmaceutical Executive Video Interview, Jim Sheehan of Lowenstein Sandler, chairman of the FDA’s Division of Regulatory Affairs, talks about what steps companies developing weight loss drugs should take to ensure they are operating responsibly and ethically.
Ensuring ethical practices, considering potential misuse
Leave a comment
